Medicines: Marketing Authorisation Holders' submission of Nitrosamine risk evaluation, risk assessment and confirmatory testing
출처기관 | MHRA | ||
---|---|---|---|
규정명 | Medicines: Marketing Authorisation Holders' submission of Nitrosamine risk evaluation, risk assessment and confirmatory testing | ||
규정 내용(요약) | 의약품: 품목허가권자의 니트로사민 위험성 평가, 위험성 평가 및 확인 테스트 제출 | ||
링크 | https://www.gov.uk/guidance/medicines-marketing-authorisation-holders-submission-of-nitrosamine-risk-evaluation | ||
재·개정일 | 2024-04-17 |